Autres langues Repligen Corporation

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
171,9 ^USD	+0,53 %		+3,08 %	-4,37 %

14/05	Transcript : Repligen Corporation Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 10:30 AM
02/05	REPLIGEN CORPORATION : UBS à l'achat	ZM

Repligen : Investor Presentation May 2024 Presentation	17/05
Repligen Corporation to Present at Upcoming May Investor Conferences	07/05
Repligen's Q1 Adjusted Earnings, Revenue Fall	01/05
(RGEN) REPLIGEN CORPORATION Sees Fiscal Year 2024 EPS Range $1.42 - $1.49	01/05
Repligen: Q1 Earnings Snapshot	01/05
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $151.3M, vs. Street Est of $150.1M	01/05
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Adjusted Q1 EPS $0.28, vs. Street Est of $0.30	01/05
Repligen Reports First Quarter 2024 Financial Results	01/05
Repligen Corporation Provides Earnings Guidance for the Fiscal Year 2024	01/05
Repligen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
North American Morning Briefing : Traders Wait for -2-	01/05
Repligen to Report First Quarter 2024 Financial Results	17/04
Repligen : Investor Presentation April 2024 Presentations	02/04
Repligen Appoints Maggie A. Pax to Board of Directors	19/03
Repligen Corporation Appoints Maggie A. Pax as Board of Directors	19/03
Repligen Insider Sold Shares Worth $681,348, According to a Recent SEC Filing	13/03
Repligen Insider Sold Shares Worth $3,298,632, According to a Recent SEC Filing	12/03
Repligen Insider Sold Shares Worth $866,204, According to a Recent SEC Filing	27/02
Aktien Frankfurt Schluss: Dax stabil vor Zahlen des Trendsetters Nvidia	21/02
Sector Update: Health Care Stocks Flat to Lower Premarket Wednesday	21/02

Aucun résultat pour cette recherche